Journal of Pediatric Epilepsy 2015; 04(01): 047-052
DOI: 10.1055/s-0035-1554792
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Ring Chromosome 20 Syndrome and Epilepsy

Atsushi Ishii
1   Department of Pediatrics, School of Medicine, Fukuoka University, Fukuoka, Japan
,
Shinichi Hirose
2   Central Research Institute for the Molecular Pathomechanisms of Epilepsy, Fukuoka University, Fukuoka, Japan
› Author Affiliations
Further Information

Publication History

25 November 2014

28 November 2014

Publication Date:
03 July 2015 (online)

Abstract

The ring chromosome 20 [r(20)] syndrome is a chromosomal disorder, characterized by refractory epilepsy, mild-to-moderate intellectual disability, and behavioral anomaly. In spite of structural chromosomal aberrations, malformations are often not recognized. In addition, neurological anomalies and abnormalities in brain magnetic resonance imagings are usually not detected. The epilepsy is refractory and mainly presents as atypical absence seizures or nocturnal frontal lobe seizures, with frequent episodes of nonconvulsive status epilepticus in typical cases. Ictal electroencephalograms performed during nonconvulsive status epilepticus episodes typically record spike wave discharges, superimposed with 2- to 3-Hz rhythmic slow waves predominantly in the frontal lesion. Since the r(20) syndrome was initially reported as a genetic syndrome in 1976, over 60 cases have been published to date. Most cases are sporadic, except four familial cases that have been previously reported. This syndrome is diagnosed only by karyotyping. Since epilepsy is the only symptom in most patients, genetic testing and diagnosis are usually delayed. In addition, patients usually exhibit mosaicism in lymphocytes, and the proportion of lymphocytes with the r(20) varies. Although some studies have evaluated the relationship between the phenotype and the proportion of lymphocytes with the r(20), no significant relationship has emerged. Ring chromosomes are usually formed by the fusion of each 20p and 20q telomere and cause the loss of both telomeres. Therefore, the r(20) syndrome is thought to be caused by haploinsufficiency of genes located on the telomeric regions of chromosome 20. However, in spite of showing typical symptoms of the r(20) syndrome, a patient in whom telomeres were not deleted has also been reported. Moreover, apart from the genes located on chromosome 20, two genes associated with epilepsy, KCNQ2 and CHRNA4, have also been located at p13ter and 13qter. Hence, the mechanism underlying seizure disorders in r(20) syndrome remains unknown. This review discusses the current knowledge about the genetic etiology of r(20) syndrome.

 
  • References

  • 1 Atkins L, Miller WL, Salam M. A ring-20 chromosome. J Med Genet 1972; 9 (3) 377-380
  • 2 Borgaonkar DS, Lacassie YE, Stoll C. Usefulness of chromosome catalog in delineating new syndromes. Birth Defects Orig Artic Ser 1976; 12 (5) 87-95
  • 3 Canevini MP, Sgro V, Zuffardi O , et al. Chromosome 20 ring: a chromosomal disorder associated with a particular electroclinical pattern. Epilepsia 1998; 39 (9) 942-951
  • 4 Steinlein OK, Mulley JC, Propping P , et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995; 11 (2) 201-203
  • 5 Singh NA, Charlier C, Stauffer D , et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998; 18 (1) 25-29
  • 6 Watanabe H, Nagata E, Kosakai A , et al. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J Neurochem 2000; 75 (1) 28-33
  • 7 Inoue Y, Fujiwara T, Matsuda K , et al. Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. Brain 1997; 120 (Pt 6) 939-953
  • 8 Nishiwaki T, Hirano M, Kumazawa M, Ueno S. Mosaicism and phenotype in ring chromosome 20 syndrome. Acta Neurol Scand 2005; 111 (3) 205-208
  • 9 Kosztolányi G. The genetics and clinical characteristics of constitutional ring chromosomes. J Assoc Genet Technol 2009; 35 (2) 44-48
  • 10 Elens I, Vanrykel K, De Waele L , et al. Ring chromosome 20 syndrome: electroclinical description of six patients and review of the literature. Epilepsy Behav 2012; 23 (4) 409-414
  • 11 Chawla J, Sucholeiki R, Jones C, Silver K. Intractable epilepsy with ring chromosome 20 syndrome treated with vagal nerve stimulation: case report and review of the literature. J Child Neurol 2002; 17 (10) 778-780
  • 12 Petit J, Roubertie A, Inoue Y, Genton P. Non-convulsive status in the ring chromosome 20 syndrome: a video illustration of 3 cases. Epileptic Disord 1999; 1 (4) 237-241
  • 13 Augustijn PB, Parra J, Wouters CH, Joosten P, Lindhout D, van Emde Boas W. Ring chromosome 20 epilepsy syndrome in children: electroclinical features. Neurology 2001; 57 (6) 1108-1111
  • 14 Stewart JM, Cavanagh N, Hughes DT. Ring 20 chromosome in a child with seizures, minor anomalies, and retardation. Arch Dis Child 1979; 54 (6) 477-479
  • 15 Back E, Voiculescu I, Brünger M, Wolff G. Familial ring (20) chromosomal mosaicism. Hum Genet 1989; 83 (2) 148-154
  • 16 Kobayashi K, Inagaki M, Sasaki M, Sugai K, Ohta S, Hashimoto T. Characteristic EEG findings in ring 20 syndrome as a diagnostic clue. Electroencephalogr Clin Neurophysiol 1998; 107 (4) 258-262
  • 17 Macleod S, Mallik A, Tolmie JL, Stephenson JB, O'Regan ME, Zuberi SM. Electro-clinical phenotypes of chromosome disorders associated with epilepsy in the absence of dysmorphism. Brain Dev 2005; 27 (2) 118-124
  • 18 Vignoli A, Canevini MP, Darra F , et al. Ring chromosome 20 syndrome: a link between epilepsy onset and neuropsychological impairment in three children. Epilepsia 2009; 50 (11) 2420-2427
  • 19 Alpman A, Serdaroglu G, Cogulu O, Tekgul H, Gokben S, Ozkinay F. Ring chromosome 20 syndrome with intractable epilepsy. Dev Med Child Neurol 2005; 47 (5) 343-346
  • 20 Biraben A, Semah F, Ribeiro MJ, Douaud G, Remy P, Depaulis A. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology 2004; 63 (1) 73-77
  • 21 Herrgård E, Mononen T, Mervaala E , et al. More severe epilepsy and cognitive impairment in the offspring of a mother with mosaicism for the ring 20 chromosome. Epilepsy Res 2007; 73 (1) 122-128
  • 22 Walleigh DJ, Legido A, Valencia I. Ring chromosome 20: a pediatric potassium channelopathy responsive to treatment with ezogabine. Pediatr Neurol 2013; 49 (5) 368-369
  • 23 Parr JR, Pang K, Mollett A , et al. Epilepsy responds to vagus nerve stimulation in ring chromosome 20 syndrome. Dev Med Child Neurol 2006; 48 (1) 80 , author reply 80
  • 24 Sauter S, von Beust G, Burfeind P , et al. Autistic disorder and chromosomal mosaicism 46,XY[123]/46,XY,del(20)(pter —> p12.2)[10]. Am J Med Genet A 2003; 120A (4) 533-536
  • 25 Baker E, Hinton L, Callen DF , et al. Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomalies. Am J Med Genet 2002; 107 (4) 285-293
  • 26 Adeyinka A, Adams SA, Lorentz CP, Van Dyke DL, Jalal SM. Subtelomere deletions and translocations are frequently familial. Am J Med Genet A 2005; 135 (1) 28-35
  • 27 Fraisse J, Bertheas MF, Frère F, Lauras B, Rolland MO, Brizard CP. Partial monosomy 20q: a new syndrome. Regional assignment of the adenosine deaminase (ADA) locus on 20q132 [in French, author's transl]. Ann Genet 1981; 24 (4) 216-219
  • 28 Shabtai F, Ben-Sasson E, Arieli S, Grinblat J. Chromosome 20 long arm deletion in an elderly malformed man. J Med Genet 1993; 30 (2) 171-173
  • 29 Ravnan JB, Tepperberg JH, Papenhausen P , et al. Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet 2006; 43 (6) 478-489
  • 30 Roberts AE, Cox GF, Kimonis V, Lamb A, Irons M. Clinical presentation of 13 patients with subtelomeric rearrangements and a review of the literature. Am J Med Genet A 2004; 128A (4) 352-363
  • 31 Béna F, Bottani A, Marcelli F, Sizonenko LD, Conrad B, Dahoun S. A de novo 1.1-1.6 Mb subtelomeric deletion of chromosome 20q13.33 in a patient with learning difficulties but without obvious dysmorphic features. Am J Med Genet A 2007; 143A (16) 1894-1899
  • 32 Traylor RN, Bruno DL, Burgess T , et al. A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33. PLoS ONE 2010; 5 (8) e12462
  • 33 Elghezal H, Hannachi H, Mougou S, Kammoun H, Triki C, Saad A. Ring chromosome 20 syndrome without deletions of the subtelomeric and CHRNA4—KCNQ2 genes loci. Eur J Med Genet 2007; 50 (6) 441-445
  • 34 Kurahashi H, Wang JW, Ishii A , et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology 2009; 73 (15) 1214-1217
  • 35 Ville D, Kaminska A, Bahi-Buisson N , et al. Early pattern of epilepsy in the ring chromosome 20 syndrome. Epilepsia 2006; 47 (3) 543-549
  • 36 Burnell RH, Stern LM, Sutherland GR. A case of ring 20 chromosome with cardiac and renal anomalies. Aust Paediatr J 1985; 21 (4) 285-286
  • 37 Jacobs PA, Matsuura JS, Mayer M, Newlands IM. A cytogenetic survey of an institution for the mentally retarded: I. Chromosome abnormalities. Clin Genet 1978; 13 (1) 37-60
  • 38 Porfirio B, Valorani MG, Giannotti A, Sabetta G, Dallapiccola B. Ring 20 chromosome phenotype. J Med Genet 1987; 24 (6) 375-377
  • 39 Conlin LK, Kramer W, Hutchinson AL , et al. Molecular analysis of ring chromosome 20 syndrome reveals two distinct groups of patients. J Med Genet 2011; 48 (1) 1-9
  • 40 Ottaviani A, Gilson E, Magdinier F. Telomeric position effect: from the yeast paradigm to human pathologies?. Biochimie 2008; 90 (1) 93-107
  • 41 Béri-Deixheimer M, Gregoire MJ, Toutain A , et al. Genotype-phenotype correlations to aid in the prognosis of individuals with uncommon 20q13.33 subtelomere deletions: a collaborative study on behalf of the ‘association des Cytogénéticiens de langue Française’. Eur J Hum Genet 2007; 15 (4) 446-452
  • 42 Kroepfl T, Petek E, Schwarzbraun T, Kroisel PM, Plecko B. Mental retardation in a girl with a subtelomeric deletion on chromosome 20q and complete deletion of the myelin transcription factor 1 gene (MYT1). Clin Genet 2008; 73 (5) 492-495